| Identification | Back Directory | [Name]
safracin A | [CAS]
87578-98-1 | [Synonyms]
Y-16760
safracin A
PubChem ID: 160293
2-Amino-N-[(6,7,9,10,13,14,14a,15-octahydro-1-hydroxy-2,11-dimethoxy-3,12,16-trimethyl-10,13-dioxo-6,15-epimino-5H-isoquino[3,2-b][3]benzazocin-9-yl)methyl]propionamide | [Molecular Formula]
C28H36N4O6 | [MOL File]
87578-98-1.mol | [Molecular Weight]
524.614 |
| Chemical Properties | Back Directory | [Boiling point ]
719.074±60.00 °C(Press: 760.00 Torr)(predicted) | [density ]
1.366±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [pka]
9.853±0.70(predicted) |
| Hazard Information | Back Directory | [Uses]
Safracin A has anti-Gram-positive bacteria, Gram-negative bacteria and anti-tumor effect[1]. | [References]
[1] T Okumoto, et al. Activity of safracins A and B, heterocyclic quinone antibiotics, on experimental tumors in mice. J Antibiot (Tokyo). 1985 Jun;38(6):767-71. DOI:10.7164/antibiotics.38.767 |
|
|